ir.chimerix.comINVESTOR RELATIONS | Chimerix, Inc.
ir.chimerix.com Profile
ir.chimerix.com
Maindomain:chimerix.com
Title:INVESTOR RELATIONS | Chimerix, Inc.
Description：Skip to main navigation Careers Contact Us About Us Who We Are Leadership Careers Our Focus Oncology Biodefense Collaborations Our Science DSTAT Brincidofovir Our Pipeline Patient Resources Expanded A
Discover ir.chimerix.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
ir.chimerix.com Information
| Website / Domain: | ir.chimerix.com |
| HomePage size: | 128.854 KB |
| Page Load Time: | 0.326502 Seconds |
| Website IP Address: | 184.50.88.3 |
| Isp Server: | Akamai Technologies Inc. |
ir.chimerix.com Ip Information
| Ip Country: | United States |
| City Name: | San Jose |
| Latitude: | 37.339389801025 |
| Longitude: | -121.89495849609 |
ir.chimerix.com Keywords accounting
| Keyword | Count |
|---|
ir.chimerix.com Httpheader
| Accept-Ranges: bytes |
| Content-Encoding: gzip |
| Content-Language: en |
| Content-Type: text/html; charset=UTF-8 |
| device: desktop |
| ETag: "1583241169" |
| Expect-CT: max-age=0, report-uri="/report-expect-ct-violation" |
| Feature-Policy: "accelerometer none;ambient-light-sensor none;autoplay self;camera none;encrypted-media none;fullscreen self;geolocation self;gyroscope none;magnetometer none;microphone none;midi none;payment none;picture-in-picture none;speaker self;sync-xhr self;usb none;vibrate none;vr none", From-Origin: same |
| Last-Modified: Tue, 03 Mar 2020 13:12:49 GMT |
| Link: http://ir.chimerix.com/; rel="shortlink", http://ir.chimerix.com/; rel="canonical", https://ir.chimerix.com/investor-relations; rel="alternate"; hreflang="en", https://ir.chimerix.com/investor-relations; rel="revision" |
| Referrer-Policy: no-referrer-when-downgrade |
| Server: nginx |
| X-Age: 353 |
| X-Cache-Hits: 1 |
| X-Content-Type-Options: nosniff |
| X-Drupal-Dynamic-Cache: UNCACHEABLE |
| X-Frame-Options: SAMEORIGIN |
| X-Generator: Drupal 8 (https://www.drupal.org) |
| X-Request-ID: v-ae59809c-5d50-11ea-aef6-2337e667ce1f |
| X-UA-Compatible: IE=edge |
| X-XSS-Protection: 1; mode=block |
| Content-Length: 18543 |
| X-EdgeConnect-MidMile-RTT: 37, 37 |
| X-EdgeConnect-Origin-MEX-Latency: 40, 40 |
| Cache-Control: public, max-age=0, s-maxage=1800 |
| Expires: Tue, 03 Mar 2020 13:18:43 GMT |
| Date: Tue, 03 Mar 2020 13:18:43 GMT |
| Connection: keep-alive |
| Vary: Accept-Encoding |
| Set-Cookie: DrupalVisitorMobile=0; path=/; Secure; HttpOnly |
| Strict-Transport-Security: max-age=15768000 ; preload |
ir.chimerix.com Meta Info
| charset="utf-8"/ |
| content="INVESTOR RELATIONS | Chimerix, Inc." name="title"/ |
| content="Chimerix, Inc." property="og:site_name"/ |
| content="website" property="og:type"/ |
| content="Drupal 8 (https://www.drupal.org)" name="Generator"/ |
| content="width" name="MobileOptimized"/ |
| content="true" name="HandheldFriendly"/ |
| content="width=device-width, initial-scale=1.0" name="viewport"/ |
184.50.88.3 Domains
| Domain | WebSite Title |
|---|
ir.chimerix.com Similar Website
| Domain | WebSite Title |
|---|---|
| Nelnet Inc - Investor Resources - Investor Services Program | |
| Exantas Investor Relations - Investor Overview | |
| Winnebago Investor Relations Investor Home | |
| Choice Hotels International - Investor Relations Home - Investor Relations | |
| Universal Technical Institute's Investor Relations - UTI Investor Relations | |
| Equitable Bank Investor Relations - Investor Relations - Overview | |
| Investor Relations - American Express Investor Relations | |
| 51Talk Investor Relations - Investor Relations Home | |
| Armstrong World Industries Investor Relations | Armstrong Flooring Investor Relations | |
| Lankan Investor - Lankan Investor - Home | |
| Investor Relations | Investor Relations | Littelfuse | |
| Matt McCall's Early Stage Investor Account : Matt McCall's Early Stage Investor | |
| Investor Relations | |
| 58.com Investor Relations - Welcome | |
| HEG Investor : HEG Investor |
ir.chimerix.com Traffic Sources Chart
ir.chimerix.com Alexa Rank History Chart
ir.chimerix.com Html To Plain Text
Skip to main navigation Careers Contact Us About Us Who We Are Leadership Careers Our Focus Oncology Biodefense Collaborations Our Science DSTAT Brincidofovir Our Pipeline Patient Resources Expanded Access Investors Press Releases Presentations Governance Financials & Fillings Stock Information Investors FAQs Request Information Contact Us Investors INVESTOR RELATIONS Chimerix is a biopharmaceutical company discovering, developing and commercializing medicines that improve outcomes and provide hope for patients with life threatening diseases. -- Mar 3, 2020 8:12 AM EST Copyright Nasdaq. Minimum 15 minutes delayed. -- Intra -- 1M 3M 6M 1Y PRESS RELEASES Date Title and Summary Toggle Summary Feb 26, 2020 Chimerix to Present at Cowen and Company 40th Annual Health Care Conference Toggle Summary Feb 25, 2020 Chimerix Reports Fourth Quarter and Year End 2019 Financial Results and Provides Operational Update Toggle Summary Feb 24, 2020 Chimerix Appoints Pratik S. Multani, M.D., to Board of Directors Toggle Summary Feb 18, 2020 Chimerix to Report Fourth Quarter and Year End 2019 Financial Results and Provide an Operational Update on February 25, 2020 View all Presentations Date Title Documents Mar 2, 2020 Chimerix Corporate Presentation - March 2020 Add Files Chimerix Corporate Presentation - March 2020 1.7 MB Jan 29, 2020 2020 ASM Biothreats Presentation Add Files 2020 ASM Biothreats Presentation 856.4 KB UPCOMING EVENTS Date Event Details Mar 4, 2020 at 8:40 AM EST Cowen and Company 40th Annual Health Care Conference Listen to Webcast View all SEC FILINGS Group 3,4,5 Annual Filings Current Reports Mergers & Acquisitions Other Proxy Filings Quarterly Filings Registration Statements Filing year - Any - 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 Items per page 10 25 50 Filing date Form Description View Feb 25, 2020 8-K Report of unscheduled material events or corporate event View HTML 0001117480-20-000005.pdf 0001117480-20-000005.rtf 0001117480-20-000005.xls Feb 25, 2020 10-K Annual report which provides a comprehensive overview of the company for the past year View HTML 0001117480-20-000006.pdf 0001117480-20-000006.rtf 0001117480-20-000006.xls EX-101.INS - XBRL INSTANCE DOCUMENT Feb 25, 2020 S-8 Securities offered to employees pursuant to employee benefit plans View HTML 0001117480-20-000008.pdf 0001117480-20-000008.rtf 0001117480-20-000008.xls Feb 25, 2020 3 Initial filing by director officer or owner of more than ten percent. View HTML 0001209191-20-012644.pdf 0001209191-20-012644.rtf 0001209191-20-012644.xls Feb 25, 2020 4 Statement of changes in beneficial ownership of securities View HTML 0001209191-20-012650.pdf 0001209191-20-012650.rtf 0001209191-20-012650.xls Feb 24, 2020 8-K Report of unscheduled material events or corporate event View HTML 0001117480-20-000002.pdf 0001117480-20-000002.rtf 0001117480-20-000002.xls Feb 14, 2020 SC 13G/A An amendment to the SC 13G filing View HTML 0001104659-20-021814.pdf 0001104659-20-021814.rtf 0001104659-20-021814.xls Feb 12, 2020 SC 13G/A An amendment to the SC 13G filing View HTML 0001258897-20-000868.pdf 0001258897-20-000868.rtf 0001258897-20-000868.xls Feb 11, 2020 4 Statement of changes in beneficial ownership of securities View HTML 0001209191-20-008297.pdf 0001209191-20-008297.rtf Feb 11, 2020 4 Statement of changes in beneficial ownership of securities View HTML 0001209191-20-008293.pdf 0001209191-20-008293.rtf Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last » Displaying 1 - 10 of 567 results FAQ Show all Investor FAQ On what stock exchange are Chimerix shares traded, and what is the ticker symbol? The Chimerix ticker is CMRX and it is traded on the Nasdaq Global Market. Where is Chimerix's corporate headquarters? 2505 Meridian Parkway Suite 100 Durham, NC 27713 Who are the members of Chimerix's Board of Directors? You can view our Board of Directors by visiting the Board of Directors section of our Investor Relations website. Who are the members of the Chimerix's management team? You can view our management team by visiting the Management section of our Investor Relations website. When does Chimerix's fiscal year end? December 31 Does Chimerix pay dividends? Chimerix does not expect to declare or pay any cash or other dividends on our common stock. Does Chimerix have a direct stock purchase plan? Chimerix does not currently have a direct stock purchase plan. Where can I find all of Chimerix's SEC filings? Where can I download and view quarterly and annual reports? Quarterly and annual reports, as well as other SEC filings, can be accessed on the Financial Information portion of our Investor Relations website or directly from the SEC at www.sec.gov . Who is Chimerix's transfer agent and who do I contact with questions about my stock certificates? How can I contact Chimerix's transfer agent? The transfer agent and registrar for our common stock is: Computershare Trust Company, N.A. The transfer agent and registrar’s address is: P.O. Box 43078 Providence, Rhode Island 02940 ARCHIVED EVENTS Date Event Details Feb 25, 2020 at 8:30 AM EST Chimerix YE 2019 Earnings Conference Call Listen to Webcast Nov 20, 2019 at 6:00 PM GMT Jefferies 2019 London Healthcare Conference Listen to Webcast Nov 13, 2019 at 11:30 AM MST Credit Suisse 28th Annual Health Care Conference Listen to Webcast View all QUARTERLY RESULTS Show all 2019 Fourth Quarter Chimerix YE 2019 Earnings Conference Call Chimerix Reports Fourth Quarter and Year End 2019 Financial Results and Provides Operational Update Form 10-K Third Quarter Chimerix Announces Third Quarter 2019 Financial Results and Provides Operational Update Form 10-Q Second Quarter Chimerix Announces Second Quarter 2019 Financial Results and Operational Update Form 10-Q First Quarter Chimerix Announces First Quarter 2019 Financial Results and Strategy Update Form 10-Q Investor Relations Investor Overview Press Releases Events & Presentations Corporate Governance Financials & Filings Stock Information Investor FAQs Request Information Shareholder Tools Print Email Alerts Subscription RSS News Feeds Share Facebook LinkedIn Twitter RSS Privacy Policy Terms & Conditions of Use Forward-Looking Statements Community Guidelines References Contact Us © 2018 Chimerix. All rights reserved. About Us Who We Are Leadership Careers Our Focus Oncology Biodefense Collaborations Our Science DSTAT Brincidofovir Our Pipeline Patient Resources Expanded Access Investors Press Releases Presentations Governance Financials & Filings Stock Information Investor FAQs Request Information Contact Us Privacy Policy Terms & Conditions of Use Forward-Looking Statements Community Guidelines References Contact Us © 2018 Chimerix. All rights reserved....
ir.chimerix.com Whois
"domain_name": "CHIMERIX.COM",
"registrar": "Network Solutions, LLC",
"whois_server": "whois.networksolutions.com",
"referral_url": null,
"updated_date": "2019-06-13 06:35:51",
"creation_date": "1999-08-12 17:43:06",
"expiration_date": "2022-08-12 17:42:53",
"name_servers": [
"NS89.WORLDNIC.COM",
"NS90.WORLDNIC.COM"
],
"status": "clientTransferProhibited https://icann.org/epp#clientTransferProhibited",
"emails": "abuse@web.com",
"dnssec": "unsigned",
"name": null,
"org": null,
"address": null,
"city": null,
"state": null,
"zipcode": null,
"country": null